127 related articles for article (PubMed ID: 9224409)
21. Matrix metalloproteinase inhibition improves survival in an orthotopic model of human pancreatic cancer.
Zervox EE; Franz MG; Salhab KF; Shafii AE; Menendez J; Gower WR; Rosemurgy AS
J Gastrointest Surg; 2000; 4(6):614-9. PubMed ID: 11307097
[TBL] [Abstract][Full Text] [Related]
22. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M
Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039
[TBL] [Abstract][Full Text] [Related]
23. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
Eccles SA; Box GM; Court WJ; Bone EA; Thomas W; Brown PD
Cancer Res; 1996 Jun; 56(12):2815-22. PubMed ID: 8665519
[TBL] [Abstract][Full Text] [Related]
24. Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice.
Winding B; NicAmhlaoibh R; Misander H; Høegh-Andersen P; Andersen TL; Holst-Hansen C; Heegaard AM; Foged NT; Brünner N; Delaissé JM
Clin Cancer Res; 2002 Jun; 8(6):1932-9. PubMed ID: 12060638
[TBL] [Abstract][Full Text] [Related]
25. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
[TBL] [Abstract][Full Text] [Related]
26. Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer.
Haq M; Shafii A; Zervos EE; Rosemurgy AS
Cancer Res; 2000 Jun; 60(12):3207-11. PubMed ID: 10866312
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.
Grossetete M; Rosenberg GA
J Cereb Blood Flow Metab; 2008 Apr; 28(4):752-63. PubMed ID: 17971790
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases of human NK cells.
Albertsson P; Kim MH; Jonges LE; Kitson RP; Kuppen PJ; Johansson BR; Nannmark U; Goldfarb RH
In Vivo; 2000; 14(1):269-76. PubMed ID: 10757086
[TBL] [Abstract][Full Text] [Related]
29. [An experimental study of matrix metalloproteinase inhibitor BB-94 inhibits the invasion and metastasis of the human salivary adenoid cystic carcinoma in vitro and in vivo].
Mao L; Yu S; Sun K
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Jul; 36(4):304-7. PubMed ID: 11718018
[TBL] [Abstract][Full Text] [Related]
30. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Deryugina EI; Soroceanu L; Strongin AY
Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer.
Hotz HG; Hines OJ; Hotz B; Foitzik T; Buhr HJ; Reber HA
J Gastrointest Surg; 2003 Feb; 7(2):220-7; discussion 227-8. PubMed ID: 12600446
[TBL] [Abstract][Full Text] [Related]
33. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
[TBL] [Abstract][Full Text] [Related]
34. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
Asahi M; Asahi K; Jung JC; del Zoppo GJ; Fini ME; Lo EH
J Cereb Blood Flow Metab; 2000 Dec; 20(12):1681-9. PubMed ID: 11129784
[TBL] [Abstract][Full Text] [Related]
35. Role of fibrillar Tenascin-C in metastatic pancreatic cancer.
Chen J; Chen Z; Chen M; Li D; Li Z; Xiong Y; Dong J; Li X
Int J Oncol; 2009 Apr; 34(4):1029-36. PubMed ID: 19287959
[TBL] [Abstract][Full Text] [Related]
36. [Effects of rofecoxib on angiogenesis of pancreatic cancer xenograft in nude mice].
Zhou XC; Tang CW; Liu CL; Wang CH
Ai Zheng; 2004 Apr; 23(4):376-80. PubMed ID: 15087022
[TBL] [Abstract][Full Text] [Related]
37. The matrix metalloproteinase inhibitor BB-94 improves the strength of intestinal anastomoses in the rat.
de Hingh IH; Siemonsma MA; de Man BM; Lomme RM; Hendriks T
Int J Colorectal Dis; 2002 Sep; 17(5):348-54. PubMed ID: 12172929
[TBL] [Abstract][Full Text] [Related]
38. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ
Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419
[TBL] [Abstract][Full Text] [Related]
39. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice].
Lai RX; Zhang SN; Nakamura T; Yuan SZ
Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131
[TBL] [Abstract][Full Text] [Related]
40. Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo.
Rigg AS; Lemoine NR
Cancer Gene Ther; 2001 Nov; 8(11):869-78. PubMed ID: 11773977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
